Award
Delivery Order #15B30727F00000003
Pharmaceutical Delivery Order Awarded to McKesson for Inmate Medication
Buyer
Federal Prison System / Bureau of Prisons
Award Amount
$18,358.83
Ceiling
$18,358.83
Awarded
August 10, 2026
Period of Performance
Aug 10, 2026 – Sep 30, 2026
Identifier
15B30727F00000003
NAICS
325412
This contract represents a delivery order awarded under a previously established indefinite delivery vehicle (IDV) with McKesson Corporation, a leading healthcare services and pharmaceutical distribution company. The order provides controlled medication for an inmate population during a specific quarter, ensuring essential pharmaceutical supplies are available in correctional facilities. This award is significant as it supports public health within the correctional system by maintaining uninterrupted access to critical medications. The scope of work involves the timely delivery of medications tailored for incarcerated individuals, focusing on quality and regulatory compliance. The award stems from a competitive framework under the existing Pharmaceutical Prime Vendor Contract with the Department of Veterans Affairs, a substantial multi-year contract known for enhancing pharmaceutical supply chains. The delivery order was recently awarded and will be performed over a brief, defined period within the year 2026 at the designated location in Irving, Texas. This award is a continuation of McKesson's pivotal role in federal pharmaceutical provision, reinforcing the company's commitment to public sector healthcare needs.
Description
MCKESSON CONTROLLED (FSA)MEDICATION FY27 Q1 MEDICATION FOR INMATE POPULATION OCT 1 - DEC 11 2026